Delivery Order SPE2DB20D2104-SPE2DB25FNBUA
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.23 for Briviact 100 mg tablets (60-count) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.12 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $5,569.98 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Briviact 50 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by July 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,624.15 to AmerisourceBergen Drug Corp for Briviact 75 mg tablets (60-count units) on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $5,136.01 to AmerisourceBergen Drug Corp for the supply of Briviact 50 mg tablets (60-count packaging) with a completion date of July 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical products will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a $1,859.98 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Briviact 50 mg tablets (60-count packages). This firm fixed-price delivery order represents a non-set-aside, competitively awarded procurement supporting federal medical supply needs. The order is scheduled for completion by August 19, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,948.70 to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count supply) on March 5, 2025, with completion expected by March 6, 2025. This firm fixed price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a delivery order valued at $4,834.48 to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count units) on August 12, 2025, with completion targeted for August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The Defense Logistics Agency awarded a $2,839.50 delivery order to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60 units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $3,263.43 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Briviact 100 mg tablets (60-count units). This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNBUADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,320.35 to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count supply) on September 26, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a vast range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its established capability as a critical vendor for the Defense Health Agency and other federal healthcare systems, consistently fulfilling diverse pharmaceutical procurement requirements across multiple therapeutic domains through competitively awarded delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/26/25 |